Use of Gamma Globulin and Erythropoietin in a Sickle Cell Aplastic Crisis

Goldstein AR , Anderson MJ , Serjeant GR Parvovirus associated aplastic crisis in homozygous sickle cell disease. Arch Dis Child. 1987;62:585-588.

Saarinen UM , Chorba TL , Tattersail P. , et al. Human parvovirus B19-induced epidemic acute red cell aplasia in patients with hereditary hemolytic anemia. Blood. 1986;67:1411-1417.

Mann MC , Votto J. , McNamee MJ Management of the severely anemic patient who refuses transfusion: lessons learned during the care of a Jehovah's Witness. Ann Intern Med. 1992; 117:1042-1048.

Sherwood JB , Goldwasser E. , Chilote R. , et al. Sickle cell anemia patients have low erythropoietin levels for their degree of anemia. Blood. 1986;67:46-49.

Nagel RL , Vichinsky W. , Shah M. , et al. F reticulocyte response in sickle cell anemia treated with recombinant human erythropoietin: a double-blind study. Blood. 1993;81:9-14.

Ozawa K. , Kurtzman G. , Young N. Replication of the B19 parvovirus in human bone marrow cell cultures. Science. 1986;233:883-886.

Austin T. , Uchiyama N. , Katz J. Treatment of child with erythropoietin (EPO) and granulocytic colony stimulating factor (G-CSF) presenting with erythroblastopenia and neutropenia secondary to human parvovirus B19 infection and complicated by cellulitis and mastoiditis . Proceedings of American Society of Pediatric Hematology/Oncology . 1992;1:30. Abstract.

Koch WC , Massey G. , Russell CE , Adler SP Manifestations and treatment ofhuman parvovirus B19 infection in immunocompromised patients. J Pediatr. 1990;116:355-359.

Kurtzman G. , Frickhofen N. , Kimball J. , et al. Pure red-cell aplasia of 10 years' duration due to persistent parvovirus B19 infection and its cure with immunoglobulin therapy. N Engl J Med. 1989; 321:519-523.

Hanada T. , Koike K. , Takeya T. , et al. Human parvovirus B19-induced transient pancytopenia in a child with hereditary spherocytosis. Br J Haematol. 1988;70:113-115.